Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ CD264 (TRAIL-R4) Monoclonal Antibody (7G7H9)
Mouse Monoclonal Antibody
Supplier: Invitrogen™ MA548654
Description
CD264 (TRAIL-R4) Monoclonal Antibody for Western Blot, ELISA
TRAIL (also known as Apo-2L) is a member of the tumor necrosis factor (TNF) ligand family that rapidly induces apoptosis in a variety of transformed cell lines. A fourth member of the emerging TRAIL receptor family, TRAIL-R4, has signaling capacity similar to that of TRAIL-R1 and TRAIL-R2 with respect to NF-kappaB activation, but differs in its inability to induce apoptosis. Like TRAIL-R1 and TRAIL-R2, this receptor shows widespread tissue expression. The human TRAIL-R4 gene has been mapped to chromosome 8p22-21, clustered with three other TRAIL receptors.
Specifications
CD264 (TRAIL-R4) | |
Monoclonal | |
1 mg/mL | |
PBS with 0.05% sodium azide | |
Q9UBN6 | |
TNFRSF10D | |
Purified recombinant fragment of human TNFRSF10D (AA: extra 56-211) expressed in E. Coli. | |
100 μg | |
Primary | |
Human, Monkey | |
Antibody | |
IgG1 |
ELISA, Western Blot | |
7G7H9 | |
Unconjugated | |
TNFRSF10D | |
CD264; DCR2; Decoy receptor 2; TNF receptor superfamily member 10d; TNF receptor-related receptor for TRAIL; TNF-related apoptosis-inducing ligand receptor 4; TNFRSF10D; TRAIL receptor 4; TRAIL receptor with a truncated death domain; TRAILR4; TRAIL-R4; TRUNDD; Tumor necrosis factor receptor superfamily member 10D; tumor necrosis factor receptor superfamily member 10d, decoy with truncated death domain; tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain; UNQ251/PRO288 | |
Mouse | |
Protein G | |
RUO | |
8793 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction